IL115299A0 - Ú1, 2, 4¾Triazolo Ú4, 3-a¾ quinoxalinone derivatives their preparation and use - Google Patents

Ú1, 2, 4¾Triazolo Ú4, 3-a¾ quinoxalinone derivatives their preparation and use

Info

Publication number
IL115299A0
IL115299A0 IL11529995A IL11529995A IL115299A0 IL 115299 A0 IL115299 A0 IL 115299A0 IL 11529995 A IL11529995 A IL 11529995A IL 11529995 A IL11529995 A IL 11529995A IL 115299 A0 IL115299 A0 IL 115299A0
Authority
IL
Israel
Prior art keywords
alkyl
independently
preparation
pox
hydrogen
Prior art date
Application number
IL11529995A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL115299A0 publication Critical patent/IL115299A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL11529995A 1994-09-16 1995-09-14 Ú1, 2, 4¾Triazolo Ú4, 3-a¾ quinoxalinone derivatives their preparation and use IL115299A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK106694 1994-09-16

Publications (1)

Publication Number Publication Date
IL115299A0 true IL115299A0 (en) 1995-12-31

Family

ID=8100607

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11529995A IL115299A0 (en) 1994-09-16 1995-09-14 Ú1, 2, 4¾Triazolo Ú4, 3-a¾ quinoxalinone derivatives their preparation and use

Country Status (22)

Country Link
EP (1) EP0781282B1 (da)
JP (1) JPH10506620A (da)
KR (1) KR970706285A (da)
CN (1) CN1193973A (da)
AT (1) ATE183186T1 (da)
AU (1) AU694554B2 (da)
CA (1) CA2200056A1 (da)
CZ (1) CZ284930B6 (da)
DE (1) DE69511420T2 (da)
DK (1) DK0781282T3 (da)
ES (1) ES2138233T3 (da)
FI (1) FI971076A7 (da)
GR (1) GR3031788T3 (da)
HU (1) HUT76802A (da)
IL (1) IL115299A0 (da)
NO (1) NO308797B1 (da)
NZ (1) NZ292108A (da)
PL (1) PL319175A1 (da)
SK (1) SK282457B6 (da)
TW (1) TW397835B (da)
WO (1) WO1996008493A1 (da)
ZA (1) ZA957794B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL125950A0 (en) * 1997-09-05 1999-04-11 Pfizer Prod Inc Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
CN1285834A (zh) 1997-11-11 2001-02-28 小野药品工业株式会社 稠合吡嗪化合物
WO2010101230A1 (ja) 2009-03-05 2010-09-10 アステラス製薬株式会社 キノキサリン化合物
BR112013005439A2 (pt) 2010-09-07 2017-09-19 Astellas Pharma Inc compostos de quinoxalina

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4354027A (en) * 1980-05-19 1982-10-12 Usv Pharmaceutical Corporation Triazoloquinoxalin-4-ones
US5153196A (en) * 1991-06-05 1992-10-06 Eli Lilly And Company Excitatory amino acid receptor antagonists and methods for the use thereof
DK162491D0 (da) * 1991-09-20 1991-09-20 Novo Nordisk As Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne
AU3767793A (en) * 1992-04-03 1993-11-08 Yamanouchi Pharmaceutical Co., Ltd. Fused quinoxalinone derivative and pharmaceutical composition containing the same
DK31093D0 (da) * 1993-03-19 1993-03-19 Novo Nordisk As
WO1994026746A1 (en) * 1993-05-06 1994-11-24 Novo Nordisk A/S [1,2,4]TRIAZOLO[4,3-a]QUINOXALINE COMPOUNDS, THEIR PREPARATION AND USE

Also Published As

Publication number Publication date
CA2200056A1 (en) 1996-03-21
KR970706285A (ko) 1997-11-03
CN1193973A (zh) 1998-09-23
FI971076L (fi) 1997-05-13
DE69511420T2 (de) 2000-03-30
NO308797B1 (no) 2000-10-30
FI971076A0 (fi) 1997-03-14
CZ75397A3 (en) 1997-08-13
GR3031788T3 (en) 2000-02-29
ZA957794B (en) 1996-05-14
SK33497A3 (en) 1998-02-04
TW397835B (en) 2000-07-11
NZ292108A (en) 1999-02-25
AU694554B2 (en) 1998-07-23
EP0781282A1 (en) 1997-07-02
DK0781282T3 (da) 2000-02-28
NO971187L (no) 1997-05-15
ES2138233T3 (es) 2000-01-01
CZ284930B6 (cs) 1999-04-14
AU3380895A (en) 1996-03-29
JPH10506620A (ja) 1998-06-30
PL319175A1 (en) 1997-08-04
HUT76802A (en) 1997-11-28
ATE183186T1 (de) 1999-08-15
NO971187D0 (no) 1997-03-14
DE69511420D1 (de) 1999-09-16
EP0781282B1 (en) 1999-08-11
SK282457B6 (sk) 2002-02-05
FI971076A7 (fi) 1997-05-13
WO1996008493A1 (en) 1996-03-21

Similar Documents

Publication Publication Date Title
IL139056A0 (en) Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
SI1070056T1 (en) Phthalazinone pde iii/iv inhibitors
PL324285A1 (en) Pyrollepyrimidines and methods of obtaining them
MX9700557A (es) Dihidrobenzofuranos.
OA09723A (en) Polycyclic guanine derivatives.
ATE179698T1 (de) Pyrrolidin- und oxazolidin derivate , ihre herstellung und ihre verwendung als thrombocyten- aggregations-hemmer
MX9702307A (es) Pirrolo (2,3-d)pirimidinas y su uso.
PL338339A1 (en) Novel derivatives of tetrazole
IL118167A0 (en) Pyrazolo (1,5a) pyrimidines their preparation and use
DE60127845D1 (de) Benzylidenthiazolidindione und ihre verwendung als antimykotische mittel
ATE163007T1 (de) Neue vitamin d derivate
SI0920426T1 (en) New thiazole derivatives with phosphodiesterase-inhibiting effect
IL150329A0 (en) 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity
GR3031788T3 (en) [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE
DE60036558D1 (de) Phthalazinon-derivate als pde 4 hemmer
CA2120782A1 (en) Thioxanthenone antitumor agents
TR200100133T2 (tr) FKBP İnhibitörleri
TW334340B (en) Preparation for pyrazolyl derivatives
CA2070120A1 (en) Thioxanthenone antitumor agents
ZA957795B (en) [1,2,4]triazolo[4,3-a]quinoxalinone derivatives their preparation and use
CA2070799A1 (en) Thioxanthenone antitumor agents
TR199801683A2 (xx) Yeni �re t�revleri.
AU6278700A (en) 1,2-dihydro-1-oxo-pyrazino[1,2-a]indole derivatives
IL169334A0 (en) Phthalazine derivatives as phosphodiesterase 4 inhibitors
TW251282B (en) Nonsteroidal triazole antiinflammatory agents